Johnson & Johnson (JNJ)
NYSE: JNJ · Real-Time Price · USD
170.59
-0.15 (-0.09%)
At close: Aug 6, 2025, 4:00 PM
170.87
+0.28 (0.17%)
After-hours: Aug 6, 2025, 7:58 PM EDT
Revance Therapeutics Analyst Ratings
Total Analysts
14
Consensus Rating
Buy
Price Target
$174.64
Upside
+2.37%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Barclays | Barclays | Hold Maintains $165 → $176 | Hold | Maintains | $165 → $176 | +3.17% | Jul 17, 2025 |
RBC Capital | RBC Capital | Buy Maintains $181 → $185 | Buy | Maintains | $181 → $185 | +8.45% | Jul 17, 2025 |
Guggenheim | Guggenheim | Hold Maintains $164 → $167 | Hold | Maintains | $164 → $167 | -2.10% | Jul 17, 2025 |
UBS | UBS | Strong Buy Maintains $180 → $190 | Strong Buy | Maintains | $180 → $190 | +11.38% | Jul 17, 2025 |
Morgan Stanley | Morgan Stanley | Hold Maintains $171 → $176 | Hold | Maintains | $171 → $176 | +3.17% | Jul 17, 2025 |
B of A Securities | B of A Securities | Hold Maintains $161 → $175 | Hold | Maintains | $161 → $175 | +2.59% | Jul 17, 2025 |
Morgan Stanley | Morgan Stanley | Hold Maintains $169 → $171 | Hold | Maintains | $169 → $171 | +0.24% | Jul 10, 2025 |
RBC Capital | RBC Capital | Buy Reiterates $181 | Buy | Reiterates | $181 | +6.10% | Jun 5, 2025 |
Leerink Partners | Leerink Partners | Buy → Hold Downgrades $169 → $153 | Buy → Hold | Downgrades | $169 → $153 | -10.31% | May 13, 2025 |
Barclays | Barclays | Hold Maintains $166 → $165 | Hold | Maintains | $166 → $165 | -3.28% | Apr 17, 2025 |
Raymond James | Raymond James | Buy Maintains $162 → $164 | Buy | Maintains | $162 → $164 | -3.86% | Apr 16, 2025 |
Morgan Stanley | Morgan Stanley | Hold Maintains $164 → $169 | Hold | Maintains | $164 → $169 | -0.93% | Apr 16, 2025 |
RBC Capital | RBC Capital | Buy Reiterates $181 | Buy | Reiterates | $181 | +6.10% | Apr 16, 2025 |
Raymond James | Raymond James | Buy Maintains $165 → $162 | Buy | Maintains | $165 → $162 | -5.04% | Apr 14, 2025 |
B of A Securities | B of A Securities | Hold Maintains $171 → $159 | Hold | Maintains | $171 → $159 | -6.79% | Apr 10, 2025 |
Morgan Stanley | Morgan Stanley | Hold Maintains $163 → $164 | Hold | Maintains | $163 → $164 | -3.86% | Apr 9, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.